Linked Life Data

12805378

Source:http://linkedlifedata.com/resource/pubmed/id/12805378

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
35
pubmed:dateCreated
2003-8-25
pubmed:abstractText
All-trans-retinoic acid (RA) is a potent inhibitor of leukemia cell proliferation and induces differentiation of acute promyelocytic leukemia cells in vitro and in vivo. For RA to induce its biological effects in target cells, binding to specific retinoic acid nuclear receptors is required. The resulting complexes bind to RA-responsive elements (RAREs) in the promoters of RA-inducible genes to initiate gene transcription and to generate protein products that mediate the biological effects of RA. In this report, we provide evidence that a member of the protein kinase C (PKC) family of proteins, PKC delta, is activated during RA treatment of the NB-4 and HL-60 acute myeloid leukemia cell lines as well as the MCF-7 breast cancer cell line. Such RA-dependent phosphorylation was also observed in primary acute promyelocytic leukemia cells and resulted in activation of the kinase domain of PKC delta. In studies aimed at understanding the functional relevance of PKC delta in the induction of RA responses, we found that pharmacological inhibition of PKC delta (but not of other PKC isoforms) diminished RA-dependent gene transcription via RAREs. On the other hand, overexpression of a constitutively active form of the kinase strongly enhanced RA-dependent gene transcription via RAREs. Gel shift assays and chromatin immunoprecipitation studies demonstrated that PKC delta associated with retinoic acid receptor-alpha and was present in an RA-inducible protein complex that bound to RAREs. Pharmacological inhibition of PKC delta activity abrogated the induction of cell differentiation and growth inhibition of NB-4 blast cells, demonstrating that its function is required for such effects. Altogether, our data provide strong evidence that PKC delta is activated in an RA-dependent manner and plays a critical role in the generation of the biological effects of RA in malignant cells.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
0021-9258
pubmed:author
pubmed:issnType
Print
pubmed:day
29
pubmed:volume
278
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
32544-51
pubmed:dateRevised
2009-11-19
pubmed:meshHeading
pubmed-meshheading:12805378-Cell Differentiation, pubmed-meshheading:12805378-Cell Division, pubmed-meshheading:12805378-Chromatin, pubmed-meshheading:12805378-Dose-Response Relationship, Drug, pubmed-meshheading:12805378-Electrophoresis, Polyacrylamide Gel, pubmed-meshheading:12805378-Enzyme Activation, pubmed-meshheading:12805378-Flow Cytometry, pubmed-meshheading:12805378-HL-60 Cells, pubmed-meshheading:12805378-Humans, pubmed-meshheading:12805378-Immunoblotting, pubmed-meshheading:12805378-Interferon-alpha, pubmed-meshheading:12805378-Luciferases, pubmed-meshheading:12805378-Precipitin Tests, pubmed-meshheading:12805378-Promoter Regions, Genetic, pubmed-meshheading:12805378-Protein Isoforms, pubmed-meshheading:12805378-Protein Kinase C, pubmed-meshheading:12805378-Protein Kinase C-delta, pubmed-meshheading:12805378-Protein Structure, Tertiary, pubmed-meshheading:12805378-Receptors, Retinoic Acid, pubmed-meshheading:12805378-Transcription, Genetic, pubmed-meshheading:12805378-Tretinoin, pubmed-meshheading:12805378-Tumor Cells, Cultured
pubmed:year
2003
pubmed:articleTitle
Activation of protein kinase C delta by all-trans-retinoic acid.
pubmed:affiliation
Robert H. Lurie Comprehensive Cancer Center and the Division of Hematology-Oncology, Northwestern University Feinberg School of Medicine and Lakeside Veterans Affairs Medical Center, Chicago, Illinois 60611, USA.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, U.S. Gov't, Non-P.H.S., Research Support, Non-U.S. Gov't